{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:42:52Z","timestamp":1786725772456,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Hypertensive disorders of pregnancy affect 5% to 10% of all pregnancies globally. The aim of treatment is to bring down blood pressure (BP) quickly and smoothly, which is safe for the mother and baby. The aim of our study was to study the efficacy and safety of intravenous labetalol and oral nifedipine in severe pregnancy-induced hypertension.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>It is a retrospective observational study, intravenous labetalol 20 mg was given initially in escalating doses of 40 mg, 80 mg, 80 mg, and 80 mg every 15 mins up to a maximum dose of 5 or until the goal BP \u2264150\/100 mmHg was reached. Some women with severe pregnancy-induced hypertension were given oral nifedipine to control their BP according to the choice of the attending consultant. Nifedipine 10 mg tablet was given initially in repeated doses of 10 mg every 15 mins up to a maximum of five doses or until the goal of BP \u2264150\/100 mmHg was reached.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In our study, we found that there was a strong statistical significance in stabilizing the BP with oral nifedipine than with intravenous labetalol drug used. The majority of the patients in the oral nifedipine group got to normal BP quicker when compared to intravenous labetalol group patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>From this study, both drugs were found to be safe and effective in the reduction in BP. The use of nifedipine may be recommended in low-resource settings since it has an oral regimen and dosage is simple when compared to incremental intravenous dosing of labetalol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2427_22","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T16:05:22Z","timestamp":1702915522000},"page":"3119-3122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the efficacy of intravenous labetalol versus oral nifedipine in patients with severe pregnancy-induced hypertension beyond 30 weeks of gestation"],"prefix":"10.4103","volume":"12","author":[{"given":"Manika","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makakmayum","family":"Rukshana","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritisha","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansalan K.","family":"Shullai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santa A.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"R2-20260511","first-page":"1","article-title":"Incidence of pregnancy induced hypertension and prescription pattern of anti-hypertensive drugs in pregnancy","volume":"5","author":"Sajith","year":"2014","journal-title":"Int J Pharma Sci Res"},{"key":"R3-20260511","first-page":"99","article-title":"Non-obstetric complications in preeclampsia","volume":"18","author":"Pankiewicz","year":"2019","journal-title":"Prz Menopauzalny"},{"key":"R5-20260511","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ultrasmedbio.2010.10.006","article-title":"Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: A randomized controlled trial","volume":"37","author":"Baggio","year":"2011","journal-title":"Ultrasound Med Biol"},{"key":"R6-20260511","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001449.pub3","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20260511","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preghy.2018.10.011","article-title":"Preeclampsia: Disease biology and burden, its management strategies with reference to India","volume":"15","author":"Malik","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"R8-20260511","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15212\/FMCH.2016.0121","article-title":"Prevalence of and risk factors for eclampsia in pregnant women in India","volume":"5","author":"Agrawal","year":"2017","journal-title":"Family Medicine and Community Health"},{"key":"R9-20260511","first-page":"e13982","article-title":"Maternal and perinatal outcomes in hypertensive disorders of pregnancy and factors influencing it: A prospective hospital-based study in Northeast India","volume":"13","author":"Panda","year":"2021","journal-title":"Cureus"},{"key":"R10-20260511","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5468\/ogs.2016.59.5.347","article-title":"Maternal uterine artery Doppler in the first and second trimesters as screening method for hypertensive disorders and adverse perinatal outcomes in low-risk pregnancies","volume":"59","author":"Scandiuzzi","year":"2016","journal-title":"Obstet Gynecol Sci"},{"key":"R11-20260511","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/01443615.2017.1309367","article-title":"Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model","volume":"37","author":"Agarwal","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"R12-20260511","article-title":"Meghalaya_factsheet_17-18.pdf"},{"key":"R13-20260511","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0002-9378(97)70004-8","article-title":"Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for preeclampsia prevention (CPEP) study group","volume":"177","author":"Sibai","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20260511","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2019.01.022","article-title":"IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial","volume":"236","author":"Zulfeen","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R15-20260511","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260511","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/01443615.2017.1308321","article-title":"A trial of oral nifedipine and oral labetalol in preeclampsia hypertensive emergency treatment","volume":"37","author":"Duro-G\u00f3mez","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"R17-20260511","doi-asserted-by":"crossref","first-page":"262.e1","DOI":"10.1016\/j.ajog.2008.06.076","article-title":"Early-onset severe preeclampsia: Induction of labor vs elective cesarean delivery and neonatal outcomes","volume":"199","author":"Alanis","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20260511","first-page":"273","article-title":"Hypertension in pregnancy: Hospital based study","volume":"54","author":"Prakash","year":"2006","journal-title":"J Assoc Physicians India"},{"key":"R19-20260511","first-page":"159","article-title":"Practice bulletin# 33: diagnosis and management of preeclampsia and eclampsia","volume":"99","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"R20-20260511","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.2006.01165.x","article-title":"The Magpie trial: A randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months","volume":"114","year":"2007","journal-title":"BJOG"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2427_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:25:26Z","timestamp":1786724726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2427_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2427_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2022-12-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}